Ready to get certified?
Free CDCES Coach App
Subscribe
eNewsletter
Download
Free Med Pocket Cards
Updates in Lifestyle Therapy for MASLD and MASH
By: Christine Craig, MS, RD, CDCES Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are now recognized as high-risk health conditions for people living with diabetes. Two … Continue reading Updates in Lifestyle Therapy for MASLD and MASH
Question of the Week | Diabetes Tech and Diabetes Distress
Kyle is a 55-year-old man with type 2 diabetes for ten years. He was recently diagnosed with retinopathy in both eyes. His grandmother lost her eyesight due to diabetes. Due … Continue reading Question of the Week | Diabetes Tech and Diabetes Distress
Rationale of the Week | Which Treatment is FDA Approved for MASH?
For last week’s practice question, we quizzed participants on FDA approved treatment for MASH. 33.75% of respondents chose the best answer. We want to clarify and share this important information, … Continue reading Rationale of the Week | Which Treatment is FDA Approved for MASH?
Question of the Week | FIB-4 of 2.83. What Action Required?
AR lives with type 2 diabetes, and their waistline is 41 inches. Since their ALT and AST levels are elevated, you know they are at risk for steatosis (MASH). You … Continue reading Question of the Week | FIB-4 of 2.83. What Action Required?
Rationale of the Week | Lifestyle Therapy for MASLD and MASH
For last week’s practice question, we quizzed participants on Lifestyle Therapy for MASLD and MASH. 83% of respondents chose the best answer. We want to clarify and share this important … Continue reading Rationale of the Week | Lifestyle Therapy for MASLD and MASH
Question of the Week | Which Treatment is FDA Approved for MASH?
MJ just discovered that in addition to their type 2 diabetes and a BMI of 31, they also have MASH. Based on this diagnosis, which FDA approved medication would help … Continue reading Question of the Week | Which Treatment is FDA Approved for MASH?
October 2025 eNews
Featured Articles ___________________________ NEW GLP-1 /GIP Indications Cheat Sheet & the Future Insulin Delivery with CeQur Simplicity Updates in Lifestyle Therapy for MASLD/MASH Welcome Astraea – New Customer Service Advocate … Continue reading October 2025 eNews
Rationale of the Week | Grandfather Avoiding Bolus Insulin
For last week’s practice question, we quizzed participants on insulin. 96% of respondents chose the best answer. We want to clarify and share this important information, so you can pass … Continue reading Rationale of the Week | Grandfather Avoiding Bolus Insulin
